Efficacy and safety of SOXIRI versus mFOLFIRINOX in advanced pancreatic cancer.

Xujia LiJinsheng HuangFenghua WangQi JiangLingli HuangShengping LiGui-Fang Guo

Published in: Therapeutic advances in medical oncology (2023)

For locally advanced or metastatic pancreatic cancer patients, the SOXIRI regimen had similar efficacy and controllable safety compared with the mFOLFIRINOX regimen.

Keyphrases

squamous cell carcinoma
small cell lung cancer